FSME-IMMUN

This brand name is authorized in Croatia, Netherlands, Poland, Romania

Active ingredients

The drug FSME-IMMUN contains one active pharmaceutical ingredient (API):

1 Encephalitis, tick borne UNII 42XD79UQQ6 - TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)

Encephalitis, tick borne suspension for injection is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (TBE). Its pharmacodynamic effect consists of the induction of a sufficiently high concentration of anti-TBE antibody to provide protection against the TBE virus. Read about Encephalitis, tick borne

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BA01	Encephalitis, tick borne, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines
Discover more medicines within J07BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-436912048, HR-H-946437793
Country: NL	Z-Index G-Standaard	Identifier(s): 14876094, 15025578
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62618, 77623
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100160723, 100160769
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64743001, W64743002, W64743005, W64743006, W64744001, W64744002, W64744005, W64744006